ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2025
Hybrid attention-based deep learning for multi-label ophthalmic disease detection on fundus images.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOphthalmic diseases significantly impact vision and quality of life. Early diagnosis using fundus images is critical for timely treatment. Traditional deep learning models often lack accuracy, interpretability, and efficiency for multi-label classification tasks in ophthalmology.
methodsWe propose HAM-DNet, a hybrid deep learning model combining EfficientNetV2 and Vision Transformers (ViT) for multi-label ophthalmic disease detection. The model includes SE (Squeeze-and-Excitation) blocks for attention-based feature refinement and a U-Net-based lesion localization module for improved interpretability. The model was trained and tested on multiple fundus image datasets (ODIR-5 K, Messidor, G1020, and Joint Shantou International Eye Centre).
resultsHAM-DNet achieved superior performance with an accuracy of 95.3%, precision of 96.2%, recall of 97.1%, AUC of 98.42, and F1-score of 96.75, while maintaining low computational cost (9.7 GFLOPS). It outperformed existing models including Shallow CNN and EfficientNet, particularly in handling multi-label classifications and reducing false positives and negatives.
conclusionsHAM-DNet offers a robust, accurate, and interpretable solution for automated detection of multiple ophthalmic diseases. Its lightweight architecture makes it suitable for clinical deployment, especially in telemedicine and resource-constrained environments.
Indexed as
Identifiers
40439748What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.